406 related articles for article (PubMed ID: 30755176)
1. Epidemiology and risk factors for multi-drug resistant hospital-acquired urinary tract infection in patients with liver cirrhosis: single center experience in Serbia.
Milovanovic T; Dumic I; Veličkovic J; Lalosevic MS; Nikolic V; Palibrk I
BMC Infect Dis; 2019 Feb; 19(1):141. PubMed ID: 30755176
[TBL] [Abstract][Full Text] [Related]
2. Prevalence, etiology and antibiotic resistance patterns of community-acquired urinary tract infections in Dhaka, Bangladesh.
Islam MA; Islam MR; Khan R; Amin MB; Rahman M; Hossain MI; Ahmed D; Asaduzzaman M; Riley LW
PLoS One; 2022; 17(9):e0274423. PubMed ID: 36107878
[TBL] [Abstract][Full Text] [Related]
3. Risk factors for healthcare-acquired urinary tract infections caused by multi-drug resistant microorganisms.
Djordjević ZM; Folić MM; Gavrilović J; Janković SM
Srp Arh Celok Lek; 2016; 144(9-10):490-6. PubMed ID: 29652464
[TBL] [Abstract][Full Text] [Related]
4. Spectrum and antibiotic resistance in community- and hospital-acquired urinary tract infections among adults: Experience from a large tertiary care center in a developing country.
Herbawi A; Abu Taha A; Aiesh BM; Sabateen A; Zyoud SH
Urologia; 2024 May; 91(2):394-402. PubMed ID: 38488375
[TBL] [Abstract][Full Text] [Related]
5. Predominant bacteria and patterns of antibiotic susceptibility in urinary tract infection in children with spina bifida.
Ortiz TK; Velazquez N; Ding L; Routh JC; Wiener JS; Seed PC; Ross SS
J Pediatr Urol; 2018 Oct; 14(5):444.e1-444.e8. PubMed ID: 29709445
[TBL] [Abstract][Full Text] [Related]
6. Antimicrobial susceptibilities of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in health care-associated urinary tract infection: focus on susceptibility to fosfomycin.
Cho YH; Jung SI; Chung HS; Yu HS; Hwang EC; Kim SO; Kang TW; Kwon DD; Park K
Int Urol Nephrol; 2015 Jul; 47(7):1059-66. PubMed ID: 26026972
[TBL] [Abstract][Full Text] [Related]
7. Urinary tract infection in children after cardiac surgery: Incidence, causes, risk factors and outcomes in a single-center study.
Kabbani MS; Ismail SR; Fatima A; Shafi R; Idris JA; Mehmood A; Singh RK; Elbarabry M; Hijazi O; Hussein MA
J Infect Public Health; 2016; 9(5):600-10. PubMed ID: 26829892
[TBL] [Abstract][Full Text] [Related]
8. [Etiologic agents and risk factors in nosocomial urinary tract infections].
Akkoyun S; Kuloğlu F; Tokuç B
Mikrobiyol Bul; 2008 Apr; 42(2):245-54. PubMed ID: 18697422
[TBL] [Abstract][Full Text] [Related]
9. An evaluation of multidrug-resistant Escherichia coli isolates in urinary tract infections from Aguascalientes, Mexico: cross-sectional study.
Ramírez-Castillo FY; Moreno-Flores AC; Avelar-González FJ; Márquez-Díaz F; Harel J; Guerrero-Barrera AL
Ann Clin Microbiol Antimicrob; 2018 Jul; 17(1):34. PubMed ID: 30041652
[TBL] [Abstract][Full Text] [Related]
10. Enterococcus and Streptococcus spp. associated with chronic and self-medicated urinary tract infections in Vietnam.
Poulsen LL; Bisgaard M; Son NT; Trung NV; An HM; Dalsgaard A
BMC Infect Dis; 2012 Nov; 12():320. PubMed ID: 23176582
[TBL] [Abstract][Full Text] [Related]
11. Evolution of antibiotic multiresistance in Escherichia coli and Klebsiella pneumoniae isolates from urinary tract infections: A 12-year analysis (2003-2014).
Arana DM; Rubio M; Alós JI
Enferm Infecc Microbiol Clin; 2017 May; 35(5):293-298. PubMed ID: 27056582
[TBL] [Abstract][Full Text] [Related]
12. Comparison of community-onset healthcare-associated and hospital-acquired urinary infections caused by extended-spectrum beta-lactamase-producing Escherichia coli and antimicrobial activities.
Saltoglu N; Karali R; Yemisen M; Ozaras R; Balkan II; Mete B; Tabak F; Mert A; Hondur N; Ozturk R
Int J Clin Pract; 2015 Jul; 69(7):766-70. PubMed ID: 25683907
[TBL] [Abstract][Full Text] [Related]
13. Community-acquired urinary tract infections: Causative agents and their resistance to antimicrobial drugs.
Đorđević Z; Folić M; Janković S
Vojnosanit Pregl; 2016 Dec; 73(12):1109-15. PubMed ID: 29341567
[TBL] [Abstract][Full Text] [Related]
14. Bacterial characteristics of importance for recurrent urinary tract infections caused by Escherichia coli.
Ejrnæs K
Dan Med Bull; 2011 Apr; 58(4):B4187. PubMed ID: 21466767
[TBL] [Abstract][Full Text] [Related]
15. Ceftolozane/tazobactam activity tested against aerobic Gram-negative organisms isolated from intra-abdominal and urinary tract infections in European and United States hospitals (2012).
Sader HS; Farrell DJ; Flamm RK; Jones RN
J Infect; 2014 Sep; 69(3):266-77. PubMed ID: 24780763
[TBL] [Abstract][Full Text] [Related]
16. Secular trends in gram-negative resistance among urinary tract infection hospitalizations in the United States, 2000-2009.
Zilberberg MD; Shorr AF
Infect Control Hosp Epidemiol; 2013 Sep; 34(9):940-6. PubMed ID: 23917908
[TBL] [Abstract][Full Text] [Related]
17. Oral fosfomycin for treatment of urinary tract infection: a retrospective cohort study.
Matthews PC; Barrett LK; Warren S; Stoesser N; Snelling M; Scarborough M; Jones N
BMC Infect Dis; 2016 Oct; 16(1):556. PubMed ID: 27729016
[TBL] [Abstract][Full Text] [Related]
18. Extended spectrum beta lactamase producing organisms causing urinary tract infections in Sri Lanka and their antibiotic susceptibility pattern -A hospital based cross sectional study.
Fernando MM; Luke WA; Miththinda JK; Wickramasinghe RD; Sebastiampillai BS; Gunathilake MP; Silva FH; Premaratna R
BMC Infect Dis; 2017 Feb; 17(1):138. PubMed ID: 28187754
[TBL] [Abstract][Full Text] [Related]
19. High rates of quinolone resistance among urinary tract infections in the ED.
Khawcharoenporn T; Vasoo S; Ward E; Singh K
Am J Emerg Med; 2012 Jan; 30(1):68-74. PubMed ID: 21075586
[TBL] [Abstract][Full Text] [Related]
20. Epidemiology and susceptibility of pathogens from SMART 2011-12 Turkey: evaluation of hospital-acquired versus community-acquired urinary tract infections and ICU- versus non-ICU-associated intra-abdominal infections.
Koksal I; Yilmaz G; Unal S; Zarakolu P; Korten V; Mulazimoglu L; Tabak F; Mete B; Oguz VA; Gulay Z; Alp E; Badal R; Lob S
J Antimicrob Chemother; 2017 May; 72(5):1364-1372. PubMed ID: 28122913
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
